Appendix

Phase 4 trials (7)

• edoxaban
• dabigatran
• warfarin
• acetylsalicylic acid
• rivaroxaban
• apixaban
• clopidogrel

Phase 2 trials (6)

• thalidomide
• fluorouracil
• palonosetron
• mitomycin
• leucovorin
• oxaliplatin

Phase 1 trials (9)

• 7-hydroxystaurosporine
• irinotecan
• paclitaxel
• trastuzumab
• carboplatin
• interleukin-12
• cetuximab
• capecitabine
• erlotinib

Other trials (2)

• ef5
• motexafin lutetium